Quotient Diagnostics (Acquired) (AIM: EKF)

A1c diabetes testing at the point of care, with results in under 4 minutes.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Quotient Diagnostics (Acquired) (AIM: EKF) plus 5589 other startups.

Start Free 7 Day Trial Now

Learn More About Quotient Diagnostics (Acquired) (AIM: EKF)

Technology/product details

Competing Startups

More

Companies We Work With